Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement
NCT ID: NCT06218615
Last Updated: 2024-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
109 participants
INTERVENTIONAL
2024-06-06
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
NCT05886764
Awareness Enhancing Interventions
NCT04683510
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
NCT06484595
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study
NCT05327452
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
NCT02356549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will answer pre-test survey questions, watch the culturally tailored decision aid video \[Fostering Opportunities in Research Using Marketing Strategies (FOR US)\] intervention, then answer post-intervention survey questions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Services Research
Participants watch a culturally tailored decision aid video. Surveys are completed before and after the video.
Educational Intervention (Video)
Watch video
Survey Administration
Answer survey questions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention (Video)
Watch video
Survey Administration
Answer survey questions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Identify as Black/African- American
* Have Current or previous diagnosis of cancer
* Speak and understand English
Exclusion Criteria
* Do not identify as Black/African- American
* Do not have a current or previous diagnosis of cancer
* Are non - English-speaking
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vida Henderson
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-00180
Identifier Type: REGISTRY
Identifier Source: secondary_id
FHIRB0020288
Identifier Type: OTHER
Identifier Source: secondary_id
RG1124067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.